Cite
HARVARD Citation
Juengel, E. et al. (2015). Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib. Journal of cellular and molecular medicine. 19 (2), pp. 430-441. [Online].